CHALOUPKA, Anna, Lenka PIHEROVA, Ilga GROCHOVA, Jana BINOVA, Jan KREJČÍ, Lenka ŠPINAROVÁ, Viktor STRANECKY, Stanislav KMOCH and Milos KUBANEK. Genetic architecture of recent-onset dilated cardiomyopathy in Moravian region assessed by whole-exome sequencing and its clinical correlates. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2019, vol. 163, No 4, p. 309-317. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2018.054.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Genetic architecture of recent-onset dilated cardiomyopathy in Moravian region assessed by whole-exome sequencing and its clinical correlates
Authors CHALOUPKA, Anna (203 Czech Republic, guarantor, belonging to the institution), Lenka PIHEROVA (203 Czech Republic), Ilga GROCHOVA (203 Czech Republic), Jana BINOVA (203 Czech Republic), Jan KREJČÍ (203 Czech Republic, belonging to the institution), Lenka ŠPINAROVÁ (203 Czech Republic, belonging to the institution), Viktor STRANECKY (203 Czech Republic), Stanislav KMOCH (203 Czech Republic) and Milos KUBANEK (203 Czech Republic).
Edition Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2019, 1213-8118.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.000
RIV identification code RIV/00216224:14110/19:00112737
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.5507/bp.2018.054
UT WoS 000506054400004
Keywords in English dilated cardiomyopathy; familial cardiomyopathy; next generation sequencing; genetic architecture; cardiac remodelling
Tags 14110115, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 24/1/2020 10:52.
Abstract
Aims. Recent-onset dilated cardiomyopathy (RODCM) is a disease of heterogeneous aetiology and clinical outcome. In this pilot study, we aimed to assess its genetic architecture and correlate genotype with left ventricular reverse remodelling (LVRR). Patients and Methods. In this multi-centre prospective observational study, we enrolled 83 Moravian patients with RODCM and a history of symptoms of less than 6 months, for whole-exome sequencing (WES). All patients underwent 12-month clinical and echocardiographic follow-up. LVRR was defined as an absolute increase in left ventricular ejection fraction > 10% accompanied by a relative decrease of left ventricular end-diastolic diameter > 10% at 12 months. Results. WES identified at least one disease-related variant in 45 patients (54%). LVRR occurred in 28 patients (34%), most often in carriers of isolated titin truncated variants, followed by individuals with a negative, or inconclusive WES and carriers of other disease-related variants (56% vs. 42% vs. 19%, P=0.041). Conclusion. A substantial proportion of RODCM cases have a monogenic or oligogenic genetic background. Carriers of non-titin disease-related variants are less likely to reach LVRR at 12-months than other individuals. Genetic testing could contribute to better prognosis prediction and individualized treatment of RODCM.
PrintDisplayed: 23/7/2024 07:15